It is a targeted therapy used in patients with chronic myeloid leukemia (CML) and Philadelphia chromosome‑positive acute lymphoblastic leukemia (Ph+ ALL) that are resistant to other treatments. With its precision action, Iclusig 15mg Tablet uses in resistant CML and Ph+ ALL targeted therapy offer hope for improved survival outcomes. You can visit Globans Pharma to know more.
Read More - https://www.globanspharma.com/products/iclusig-15mg-tablet
